Abstract
Objective: Collecting and synthesizing relevant data on COVID-19 from official sources of some different regulatory agencies around the world.
 Methods: The information and actions related to responding to the COVID-19 situation were collected from the websites of some regulatory agencies, including the US Food and Drug Administration (FDA), the European Medicines Agency (EMA), Health Canada (HC), Swiss Agency for Therapeutic Products (Swissmedic), and the Australian Therapeutic Goods Administration (TGA).
 Results: All the regulatory agencies help in expediting the development of COVID-19 treatments and medical devices. These agencies also developed an international regulatory collaboration to develop cure models for the pandemic. While some of the agencies conduct the COVID-19 testing, like the US FDA, the others do not. The agencies also differ in their approaches towards resolving the pandemic. FDA and EMA are more aggressive in a way that they prioritize more testing and hospitalization coverage. However, as of the 22nd of June 2021, the FDA authorized the highest number (388) of diagnostic COVID-19 test kits followed by TGA (128), and EMA (88).
 Conclusions: Although the regulatory agencies differ in their approaches towards resolving pandemic COVID-19, all regulatory agencies help in expediting the development of COVID-19 treatments and medical devices.
Highlights
The information and actions related to responding to the COVID-19 situation were collected from the websites of some regulatory agencies, including the US Food and Drug Administration (FDA), the European Medicines Agency (EMA), Health Canada (HC), Swiss Agency for Therapeutic Products (Swissmedic), and the Australian Therapeutic Goods Administration (TGA)
Conclusions: the regulatory agencies differ in their approaches towards resolving pandemic COVID-19, all regulatory agencies help in expediting the development of COVID-19 treatments and medical devices
According to the World Health Organization (WHO) [1], COVID-19 is a brand-new strand of coronavirus that was discovered when an outbreak started in Wuhan, China in December 2019
Summary
According to the World Health Organization (WHO) [1], COVID-19 is a brand-new strand of coronavirus that was discovered when an outbreak started in Wuhan, China in December 2019. During the earlier months of 2020, the virus became a global pandemic. As per WHO's June 22nd situation report [2], the number of weekly infected individuals has globally reached more than 2.5 million while the death toll is more than 64,000 deaths. Because COVID-19 is highly communicable, several countries have issued lockdown orders to keep citizens safe and prevent the further spread of the virus. The lockdown orders have been effective for months already. Because of the threat of being infected and strict stay-athome regulations, the masses started to feel peritraumatic psychological distress of varying degrees [4]. A study [5] suggests that since mobile technology is accessible for many, individuals should take advantage of online psychoeducation and intervention that typically promotes cognitive behavior therapy (CBT) and mindfulness-based therapy (MBT)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
